Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To be aware of drugs likely to come off patent soon to help budget

— Hospital pharmacist, UK

To have more information regarding the patents and generic products available

— Project manager, bioequivalence studies, Brazil

To identify pharmaceutical product patents and process patents, and drug patent expiries

— Global pharmaceutical regulatory affairs, India

To get accurate and reliable patency status in Saudi Arabia and Middle East countries

— Director, business development, Saudi Arabia

For patent and exclusivity due dligience

— Pharma investment firm, USA

Generated: May 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206531

« Back to Dashboard
NDA 206531 describes FAMOTIDINE, which is a drug marketed by Perrigo, Sandoz, Mylan, Watson Labs, Hospira, Carlsbad, Apothecon, Fresenius Kabi Usa, Apotex, Ivax Sub Teva Pharms, Teva, Alembic Pharms Ltd, Dr Reddys Labs Ltd, Navinta Llc, Aurobindo Pharma Ltd, Wockhardt, Sun Pharm Inds, Lupin Ltd, Mylan Labs Ltd, Apotex Inc, Actavis Elizabeth, Athenex Inc, Perrigo R And D, Mylan Pharms Inc, Sun Pharm Inds Ltd, West-ward Pharms Int, Hi-tech Pharma Co, Novel Labs Inc, Eurohlth Intl Sarl, Abbvie, and Baxter Hlthcare, and is included in sixty-one NDAs. It is available from one hundred and seventeen suppliers. Additional details are available on the FAMOTIDINE profile page.

The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and sixty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

Summary for NDA: 206531

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 206531

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FAMOTIDINE
famotidine
 TABLET;ORAL 206531 ANDA Wal-Mart Stores, Inc. 49035-505 49035-505-35 1 BOTTLE in 1 CARTON (49035-505-35) > 25 TABLET, FILM COATED in 1 BOTTLE
FAMOTIDINE
famotidine
 TABLET;ORAL 206531 ANDA AvPAK 50268-302 50268-302-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-302-15) > 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-302-11)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Apr 26, 2016TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength20MG
Approval Date:Apr 26, 2016TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To check antibiotic drug patent information

— Pharmacist, Denmark

To be able to inform my clients with Part D prescription plans when a brand name drug is going off patent

— Pharmacist, USA

To find key patent expiry dates on specific drugs and delivery devices

— Private equity professional, USA

For patent explorations of some brand products

— Pharma advertising, Russia

To know which brands are on and off patent

— Advertising sales pharma companies, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot